Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Grindr Inc. completed its acquisition of PurposeMed Inc. (parent of Freddie, a telehealth provider) for an upfront price of $250 million, consisting of $190 million in cash and $60 million in common stock. The deal includes an additional earnout of up to $70 million based on 2027 financial performance targets. The acquisition integrates HIV prevention care and telehealth capabilities into the Grindr app under its Grindr Health business unit.
ISQ Open Infrastructure Co Capital Raise of $29.5M
ISQ Open Infrastructure Company LLC issued and sold unregistered shares across multiple classes for total aggregate net consideration of approximately $29.5 million. The shares were sold to investors for cash and issued to independent directors for services rendered. The company also reported its monthly Transactional Net Asset Value (NAV) per share as of September 30, 2026.
Theriva Biologics Divestiture to Biossil Labs Inc.
Theriva Biologics completed the sale of its antibiotic-degrading enzyme portfolio, including SYN-004 (ribaxamase), to Biossil Labs Inc. for an upfront payment of $350,000. Theriva is eligible for up to $91 million in regulatory and sales milestones plus royalties, while Biossil assumes all future development costs and responsibilities.
Navient LLC entered into a Distribution Agreement to distribute all issued and outstanding capital stock of E Parent, Inc. to Navient Holdings, Inc. This internal separation or spin-off of a subsidiary unit was completed on November 2, 2026.
NorthStrive Acquisition Corp I Signs $350M M&A Deal with Nuclea Energy Inc.
NorthStrive Acquisition Corp I (SPAC) has entered into a definitive business combination agreement to acquire Nuclea Energy Inc., a developer of advanced nuclear technologies. The transaction values Nuclea at an enterprise value of $350 million and is expected to close in the first half of 2027, resulting in the combined company being renamed Nuclea-X Inc. and listing on Nasdaq.
Third Point Private Capital Partners Capital Raise of $1.15M
Third Point Private Capital Partners sold 42,493 Class I common shares in an unregistered private placement for total consideration of $1.15 million. The offering was conducted in reliance on Section 4(a)(2) and Regulation D/S exemptions for accredited investors and non-U.S. persons. The fund also disclosed a Net Asset Value (NAV) per share of $27.06 as of September 30, 2026.
Benchmark 2026-V24 Mortgage Trust Capital Raise of $759M
Benchmark 2026-V24 Mortgage Trust entered into agreements to sell $682.4 million of publicly offered certificates and $76.9 million of privately offered certificates. The transaction is structured as a commercial mortgage-backed securities (CMBS) offering with a closing date expected on or about November 13, 2026.
Cottonwood Communities, Inc. issued and sold 201,123 shares of its Series 2025 Preferred Stock in a private placement offering between October 19 and November 1, 2026. The company received aggregate proceeds of approximately $2.01 million from the sale, which is part of a larger $150 million private offering launched in December 2024.
Macquarie Infrastructure Fund Capital Raise of $950K
Macquarie Infrastructure Fund, L.P. sold unregistered Class I limited partnership units for $0.95 million as part of its continuous private offering. The broader MIF Program, which includes the Fund and other Macquarie-managed vehicles, has raised approximately $1,191.7 million in aggregate cash consideration since October 2025.
Supernus Pharmaceuticals, Inc. notified Nasdaq of the completion of its merger on November 2, 2026, and requested the suspension and delisting of its common stock. The company intends to deregister its shares and suspend its reporting obligations under the Exchange Act as it will no longer be listed on any national securities exchange.
Kenvue Inc. completed its merger with Kimberly-Clark Corporation, with Kenvue surviving as a direct wholly owned subsidiary of Kimberly-Clark. Under the terms of the agreement, Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each share of Kenvue common stock held. In connection with the closing, Kenvue terminated its $4.0 billion revolving credit facility and its existing long-term incentive plans.
Supernus Pharmaceuticals M&A Deal with Indivior Pharmaceuticals, Inc.
Supernus Pharmaceuticals completed its previously announced merger with Indivior Pharmaceuticals, with Supernus becoming a wholly owned subsidiary of the combined entity, which has been renamed Supernus, Inc. Supernus stockholders received 1.5401 shares of the combined company for each share held, and the transaction was supported by a new $650 million senior secured term loan facility.
Indivior Pharmaceuticals M&A Deal with Supernus Pharmaceuticals, Inc.
Indivior Pharmaceuticals completed its previously announced merger with Supernus Pharmaceuticals, with the combined entity renamed Supernus, Inc. (Nasdaq: SUPN). To fund a $1.0 billion special cash dividend to legacy Indivior stockholders, the company entered into a $650 million senior secured term loan facility with Citibank.
QCR Holdings' subsidiary, Cedar Rapids Bank and Trust Company, has entered into a definitive agreement to sell its Community Bank & Trust division to BankIowa. The divestiture includes three branch locations in the Waterloo-Cedar Falls area, involving approximately $140 million in deposits, $29 million in loans, and $153 million in assets under management. The transaction is expected to close in the first quarter of 2027 as part of the company's strategy to optimize resources and focus on high-growth markets.
Karyopharm Therapeutics has filed for voluntary Chapter 11 bankruptcy protection to implement a Restructuring Support Agreement and a planned merger with Ayrmid Ltd. The company secured $55 million in debtor-in-possession (DIP) financing to maintain operations during the court-supervised sale process. Existing equity holders are warned that their common and preferred stock will likely have no value and experience a complete loss.
CBIZ Signs $5B M&A Deal with Grant Thornton Advisors LLC
CBIZ, Inc. has completed its merger with Grant Thornton Advisors LLC, an affiliate of Grant Thornton, in an all-cash transaction with an enterprise value of $5 billion. As a result of the merger, CBIZ became a wholly owned subsidiary of Grant Thornton Advisors and its common stock has ceased trading on the NYSE.
Kimberly-Clark Corporation completed its acquisition of Kenvue Inc. on November 2, 2026, creating a global consumer health and wellness leader with 10 billion-dollar brands. Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each share of Kenvue common stock held.
FG Imperii Acquisition Signs $350M M&A Deal with tZERO Group, Inc.
FG Imperii Acquisition Corp. (FGII) has entered into a definitive merger agreement to acquire tZERO Group, Inc., a leader in tokenization infrastructure, at a pre-money equity valuation of $350 million. Upon closing, the combined company is expected to trade on the NYSE American under the ticker symbol 'TZRO'. The transaction aims to scale tZERO's regulated multi-asset infrastructure-as-a-service solutions and leverage its blockchain patent portfolio.
Value
$350M
Counterparty
tZERO Group, Inc.
“We have talked about the next phase of tZERO’s evolution requiring a more independent footprint. This transaction delivers that objective, unlocks growth paths and strengthens our ability to scale market infrastructure required for an increasingly tokenized financial system.”
Bank7 M&A Deal with Century Financial Services Corporation
Bank7 Corp. completed its acquisition of Santa Fe-based Century Financial Services Corporation, the parent company of Century Bank. Century shareholders received a combination of $210.41 in cash and 3.7052 shares of Bank7 common stock per share, while non-accredited investors received $426.53 in cash. The merger expands Bank7's footprint into New Mexico and pairs its high-performing bank with Century's core deposit franchise.
Kewaunee Scientific Signs $55M M&A Deal with NYCOM, Inc.
Kewaunee Scientific Corporation entered into a definitive agreement to acquire NYCOM, Inc., the largest laboratory dealer in the USA, for an aggregate purchase price of $55 million. The deal will be funded through $30 million in cash, a $20 million subordinated seller note, and $5 million in Kewaunee common stock. The acquisition aims to integrate NYCOM's laboratory design and project delivery expertise with Kewaunee's manufacturing capabilities.
Value
$55M
Counterparty
NYCOM, Inc.
“Nycom is an exceptional business, and we know firsthand the quality of their team and the work they deliver. We believe there is no better company in our industry at what they do. Bringing Nycom directly under the Kewaunee umbrella will broaden what we can offer our customers and provide a strong foundation for building a larger North American business.”
Thomas D. Hull III, President and Chief Executive Officer of Kewaunee Scientific Corporation
“We see this as a tremendous opportunity to build on what our team has accomplished, bring additional resources to our business, and create synergies that expand and improve our ability to deliver successful projects with the highest quality products. There is no better manufacturing partner than Kewaunee, and we are proud to join its portfolio of businesses.”
Lumentum Holdings Signs $115B M&A Deal with Marvell Technology, Inc.
Lumentum Holdings Inc. has entered into a definitive agreement to be acquired by Marvell Technology, Inc. in an all-stock transaction with an implied enterprise value of $115 billion. Lumentum stockholders will receive 4.500 shares of Marvell common stock for each share of Lumentum common stock, resulting in Lumentum stockholders owning approximately 33% of the combined company.
Colony Bankcorp M&A Deal with First Reliance Bancshares, Inc.
Colony Bankcorp, Inc. completed its merger with First Reliance Bancshares, Inc., expanding its footprint into South Carolina and creating a Southeast community banking franchise with approximately $5 billion in assets. First Reliance shareholders received either $19.75 in cash or 0.94 shares of Colony common stock per share, subject to proration. The transaction includes the merger of First Reliance Bank into Colony Bank.
Counterparty
First Reliance Bancshares, Inc.
“Today marks an important milestone in Colony's continued growth. From the beginning, we recognized a strong alignment between our teams, cultures, and approach to community banking. First Reliance has built an outstanding organization with deep customer relationships and a strong reputation in its markets. Together, we have the talent, scale, and capabilities to compete effectively and capitalize on the opportunities ahead.”
T. Heath Fountain, Chief Executive Officer of Colony
“This partnership allows us to build on the strong foundation First Reliance has established over the past 27 years. Colony shares our belief in strong relationships, local leadership, and investing in the communities we serve. I'm proud of what our team has accomplished and confident that, as part of Colony, we will create even greater opportunities for our customers, team members, and shareholders.”
Rick Saunders, Founder and Chief Executive Officer of First Reliance
Bloomin' Brands Signs $26.3M M&A Deal with Cerca Trova Restaurant Group Holdings, Inc.
Bloomin’ Brands entered into a stalking horse asset purchase agreement to acquire substantially all assets of its franchisee, Out West Restaurant Group, for $26.3 million plus the assumption of certain liabilities. The transaction follows Out West's voluntary Chapter 11 bankruptcy filing and is intended to secure 61 Outback Steakhouse restaurants in the western United States and mitigate operational disruption.
Value
$26.3M
Counterparty
Cerca Trova Restaurant Group Holdings, Inc. (Out West Restaurant Group)
Axcelis Technologies M&A Deal with Veeco Instruments Inc.
Axcelis Technologies and Veeco Instruments provided a status update on their pending merger, now expecting the deal to close by the end of the first quarter of 2027. The delay is attributed to ongoing regulatory review by China's State Administration for Market Regulation (SAMR) and the need to refile for HSR Act clearance due to the expiration of the previous waiting period.
Marvell Technology M&A Deal with Lumentum Holdings Inc.
Marvell Technology, Inc. has entered into a definitive agreement to acquire Lumentum Holdings Inc. in an all-stock transaction. Under the terms of the agreement, Lumentum common stockholders will receive 4.500 shares of Marvell common stock for each share held. The deal includes the acquisition of Lumentum's Series A Preferred Stock, which will be converted into Marvell common stock or a new series of Marvell Series B Preferred Stock.
Veeco Instruments M&A Deal with Axcelis Technologies, Inc.
Veeco Instruments and Axcelis Technologies provided a status update on their pending all-stock merger, now expecting the deal to close by the end of Q1 2027. The delay is attributed to pending regulatory approval from China's SAMR and the need to refile for HSR Act clearance due to the expiration of the previous waiting period.
NRx Pharmaceuticals received FDA approval for its Abbreviated New Drug Application (ANDA) for Preservative-Free Ketamine ahead of its November 10 goal date. The product is an American-manufactured formulation that eliminates the use of benzethonium chloride, a preservative the FDA has declined to designate as safe. The company aims to address the ongoing national shortage of ketamine using modern high-volume manufacturing technology in partnership with Nephron Pharmaceuticals.
“We are excited to bring Preservative-Free Ketamine to market and to give patients and their physicians an option for repeat treatments without the potential dangers of a preservative that has been classified as unacceptable for inclusion in multiple product categories by the US Food and Drug Administration.”
Jonathan Javitt, MD, MPH, the company’s Chairman and Chief Executive Officer
Marvell Technology Signs $115B M&A Deal with Lumentum Holdings Inc.
Marvell Technology has entered into a definitive agreement to acquire Lumentum in an all-stock transaction with an implied enterprise value of $115 billion. Lumentum stockholders will receive 4.5 shares of Marvell common stock for each share owned, resulting in approximately 33% ownership of the combined company. The merger aims to create a leader in AI connectivity by combining Marvell's electrical and optical interconnect strengths with Lumentum's high-performance laser and optical switching expertise.
Value
$115B
Counterparty
Lumentum Holdings Inc.
“AI infrastructure is undergoing a fundamental architectural shift toward optical connectivity, creating an opportunity that comes along once in a generation. The companies that move first and help define this transition will set the standard for decades to come. By bringing together two leaders with highly complementary technologies, exceptional talent and specialized manufacturing capabilities, we intend to help shape the next era of AI connectivity and create exceptional stockholder value”
Superior Group of Companies Signs $33.3M M&A Deal with Select VoiceCom
Superior Group of Companies' subsidiary, The Office Gurus, acquired Philippines-based BPO provider Select VoiceCom for approximately $26.9 million in cash plus a potential $6.4 million earn-out. The deal establishes the company's direct operating presence in the Philippines with delivery centers in Cebu City and Davao, expanding its global contact center footprint.
AAR CORP. announced it has entered into a definitive agreement to acquire a 65% controlling interest in MRO Holdings, Inc. at an implied enterprise value of approximately $4.0 billion. To fund the transaction, the company launched a private offering of $1.915 billion in senior notes, consisting of $955 million due 2031 and $960 million due 2034.